Urinary Hypoxia-Inducible Factor-1alpha Levels Are Associated with Histologic Chronicity Changes and Renal Function in Patients with Lupus Nephritis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Tubulointerstitial hypoxia in the kidney is considered a hallmark of injury and a mediator of the progression of tubulointerstitial fibrosis. Hypoxia-inducible factor-1alpha (HIF-1alpha), a master transcription factor in cellular adaptation to hypoxia,regulates a wide variety of genes, some of which are closely associated with tissue fibrosis. The present study set out to characterize urinary HIF-1alpha expressions in patients with lupus nephritis (LN) and to explore whether urinary HIF-1alpha expressions are associated with histologic chronicity changes and renal function. Materials and Methods: Urinary HIF-1alpha levels were measured by enzyme-linked immunosorbent assays in 42 patients with LN and in 30 healthy controls. Activity and chronicity indexes as well as tubular HIF-1alpha expressions were analyzed for each specimen. Results: Urinary HIF-1alpha levels were higher in LN patients than in healthy controls (3.977±1.696 vs. 2.153±0.554 ng/mL, p<0.001) and were associated with histologic chronicity indexes (r=0.463, p<0.01) and eGFR (r=-0.324, p<0.05). However, urinary HIF-1alpha levels showed no correlation with histologic activity indexes, anti-dsDNA, ANA, complement 3 and 4 levels, proteinuria, systemic lupus erythematosis disease activity index, and WHO pathological classification (p>0.05). Conclusion: Urinary HIF-1alpha levels were elevated in LN patients and were associated with histologic chronicity changes and renal function, indicating that HIF-1alpha might contribute to histologic chronicity in LN.
Abstract
Purpose: Tubulointerstitial hypoxia in the kidney is considered a hallmark of injury and a mediator of the progression of tubulointerstitial fibrosis. Hypoxia-inducible factor-1alpha (HIF-1alpha), a master transcription factor in cellular adaptation to hypoxia,regulates a wide variety of genes, some of which are closely associated with tissue fibrosis. The present study set out to characterize urinary HIF-1alpha expressions in patients with lupus nephritis (LN) and to explore whether urinary HIF-1alpha expressions are associated with histologic chronicity changes and renal function. Materials and Methods: Urinary HIF-1alpha levels were measured by enzyme-linked immunosorbent assays in 42 patients with LN and in 30 healthy controls. Activity and chronicity indexes as well as tubular HIF-1alpha expressions were analyzed for each specimen. Results: Urinary HIF-1alpha levels were higher in LN patients than in healthy controls (3.977±1.696 vs. 2.153±0.554 ng/mL, p<0.001) and were associated with histologic chronicity indexes (r=0.463, p<0.01) and eGFR (r=-0.324, p<0.05). However, urinary HIF-1alpha levels showed no correlation with histologic activity indexes, anti-dsDNA, ANA, complement 3 and 4 levels, proteinuria, systemic lupus erythematosis disease activity index, and WHO pathological classification (p>0.05). Conclusion: Urinary HIF-1alpha levels were elevated in LN patients and were associated with histologic chronicity changes and renal function, indicating that HIF-1alpha might contribute to histologic chronicity in LN.
참고문헌 (45)
- Bagavant H, "Pathogenesis of kidney disease in systemic lupus erythematosus", Curr Opin Rheumatol, 21, pp.489~494 (2009)
- Yu F, "Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system", Kidney Int, 77, pp.820~829 (2010)
- Rodríguez-Iturbe B, "Tubulointerstitial damage and progression of renal failure", Kidney Int Suppl, pp.S82~S86 (2005)
- Nangaku M., "Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure", J Am Soc Nephrol, 17, pp.17~25 (2006)
- Eckardt KU, "Rosenberger C, Wiesener MS, et al. Role of hypoxia in the pathogenesis of renal disease", Kidney Int Suppl, pp.S46~S51 (2005)
- Heyman SN, "Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease", Am J Nephrol, 28, pp.998~1006 (2008)
- Fine LG, "Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics", Kidney Int, 74, pp.867~872 (2008)
- Palm F, "Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability", Am J Physiol Renal Physiol, 294, pp.30~37 (2008)
- Fine LG, "Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia", Kidney Int Suppl, 75, pp.22~26 (2000)
- Haase VH, "Hypoxia-inducible factors in the kidney", Am J Physiol Renal Physiol, 291, pp.271~281 (2006)
- Nangaku M, "Hypoxia and hypoxia-inducible factor in renal disease", Nephron Exp Nephrol, 110, pp.1~7 (2008)
- Henze AT, "Feedback regulators of hypoxia-inducible factors and their role in cancer biology", Cell Cycle, 9, pp.2749~2763 (2010)
- Semenza GL, "Regulation of mammalian O2 homeostasis by hypoxia- inducible factor 1", Annu Rev Cell Dev Biol, 15, pp.551~578 (1999)
- Pugh CW, "Regulation of gene expression by oxygen levels in mammalian cells", Adv Nephrol Necker Hosp, 29, pp.191~206 (1999)
- Sowter HM, "HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors", Cancer Res, 61, pp.6669~6673 (2001)
- Maxwell PH, "Inducible operation of the erythropoietin 3’ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism", Proc Natl Acad Sci U S A, 90, pp.2423~2427 (1993)
- Wiesener MS, "Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha", Blood, 92, pp.2260~2268 (1998)
- Higgins DF, "Hypoxic induction of Ctgf is directly mediated by Hif-1", Am J Physiol Renal Physiol, 287, pp.1223~1232 (2004)
- Higgins DF, "Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition", J Clin Invest, 117, pp.3810~3820 (2007)
- Hochberg MC, "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum, 40, pp.1725~ (1997)
- Weening JJ, "The classification of glomerulonephritis in systemic lupus erythematosus revisited", Kidney Int, 65, pp.521~530 (2004)
- Austin HA 3rd, "Prognostic factors in lupus nephritis. Contribution of renal histologic data", Am J Med, 75, pp.382~391 (1983)
- Manotham K, "Transdifferentiation of cultured tubular cells induced by hypoxia", Kidney Int, 65, pp.871~880 (2004)
- Norman JT, "Hypoxia promotes fibrogenesis in human renal fibroblasts", Kidney Int, 58, pp.2351~2366 (2000)
- Norman JT, "Hypoxia-induced changes in extracellular matrix metabolism in renal cells", Exp Nephrol, 7, pp.463~469 (1999)
- Kudo Y, "Modification in the von Hippel-Lindau protein is involved in the progression of experimentally induced rat glomerulonephritis", Nephron Exp Nephrol, 106, pp.97~106 (2007)
- Rosenberger C, "Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia", Kidney Int, 67, pp.531~542 (2005)
- Nangaku M, "Activation of the renin-angiotensin system and chronic hypoxia of the kidney", Hypertens Res, 31, pp.175~184 (2008)
- Higgins DF, "Hypoxia-inducible factor signaling in the development of tissue fibrosis", Cell Cycle, 7, pp.1128~1132 (2008)
- Haase VH., "Pathophysiological Consequences of HIF Activation: HIF as a modulator of fibrosis", Ann N Y Acad Sci, 1177, pp.57~65 (2009)
- Rosenberger C, "Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney", Nephrol Dial Transplant, 23, pp.3472~3478 (2008)
- Nangaku M, "Hypoxia and the HIF system in kidney disease", J Mol Med (Berl), 85, pp.1325~1330 (2007)
- Hill P, "Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury", J Am Soc Nephrol, 19, pp.39~46 (2008)
- Tanaka T, "Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis", Kidney Int, 68, pp.2714~2725 (2005)
- Tanaka T, "Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model", Lab Invest, 85, pp.1292~1307 (2005)
- 송영림, "Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney", NEPHROLOGY DIALYSIS TRANSPLANTATION, 25(1), pp.77~85, OXFORD UNIV PRESS
- Yu X, "Transient hypoxia- inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine", Nephrology (Carlton), 17, pp.58~67 (2012)
- Ohtomo S, "Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model", Nephrol Dial Transplant, 23, pp.1166~1172 (2008)
- Iwano M, "Mechanisms of tubulointerstitial fibrosis", Curr Opin Nephrol Hypertens, 13, pp.279~284 (2004)
- Klahr S, "Progression of chronic renal disease", Am J Kidney Dis, 41(3 Suppl 1), pp.3~7 (2003)
- Kimura K, "Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis", Am J Physiol Renal Physiol, 295, pp.1023~1029 (2008)
- Basu RK, "Interdependence of HIF-1α and TGF-β", Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression, 2011, pp.300, 898~905
- Wang Z, "Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells", Kidney Int, 79, pp.300~310 (2011)
- Fine LG, "Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics", Kidney Int, 74, pp.867~872 (2008)
- Zhu Q, "Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats", Hypertension, 58, pp.657~664 (2011)